Clinical Trial Update: A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating lenalidomide and obinutuzumab added to CHOP chemotherapy for diffuse large B-cell lymphoma has completed enrollment with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Lenalidomide (lenalidomide)
• Obinutuzumab (obinutuzumab)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-09-19